Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drug Delivery: Overview01:16

Drug Delivery: Overview

345
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
345
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

606
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
606
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous Enhancement of Adsorption Kinetics and Capacity in MOFs for Arid-Environment Atmospheric Water Harvesting via Ordered Mesopore Engineering.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

A Square-Net Europium(III) Metal-Organic Framework for Red-Emitting LEDs and Optical Temperature Sensing.

Inorganic chemistry·2026
Same author

Behavioral, Biochemical, and <i>In Silico</i> Evidence for Extraction-Dependent Neuroprotective Effects of <i>Citrus limon</i> Leaf Essential Oils in Scopolamine-Challenged Zebrafish.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Porphyrin-based zinc metal-organic framework loaded with gallic acid as a novel nanoplatform exhibiting H<sub>2</sub>O<sub>2</sub>-activated reactive oxygen species generation and cytotoxicity in breast cancer cells.

RSC advances·2026
Same author

Cu-Gallate MOF-Chitosan Hybrid Membrane for Low-Power, Non-Invasive Acetone Sensing: Toward Early-Stage Diabetes Detection.

ACS omega·2026
Same author

Pre-synthetic redox control of structure and properties in copper TTFtt coordination polymers.

Chemical science·2025

Related Experiment Video

Updated: Aug 7, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K

BioMOF-Based Anti-Cancer Drug Delivery Systems.

Sandy Elmehrath1, Ha L Nguyen2,3, Sherif M Karam4,5

  • 1Department of Chemistry, United Arab Emirates University, Al-Ain 15551, United Arab Emirates.

Nanomaterials (Basel, Switzerland)
|March 11, 2023
PubMed
Summary

Metal-organic frameworks (MOFs) show promise as advanced drug delivery systems (DDSs) for cancer treatment due to their unique nanostructure. These materials offer high surface area and porosity for effective drug loading and targeted delivery.

Keywords:
BioMOFscancer treatmentchemical modificationdrug deliverymetal–organic frameworksnanostructures

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.4K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Related Experiment Videos

Last Updated: Aug 7, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.4K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Nanomaterials are crucial for biomedical applications, including drug delivery systems (DDSs) for cancer therapy.
  • Effective DDSs require biocompatibility, high surface area, porosity, and chemical functionality.
  • Metal-organic frameworks (MOFs) are a class of nanomaterials offering these desirable characteristics.

Purpose of the Study:

  • To review the development and applications of MOF-based DDSs for cancer treatment.
  • To provide an overview of MOF nanostructures, their synthesis, and their mechanism of action in drug delivery.

Main Methods:

  • Review of recent scientific literature on MOF nanostructures for drug delivery.
  • Analysis of MOF properties relevant to DDS efficacy (biocompatibility, surface area, porosity, functionality).
  • Examination of MOF-based DDS applications in cancer therapy.

Main Results:

  • MOFs possess tunable structures with high surface area, interconnected porosity, and versatile chemical functionality.
  • These properties enable efficient drug loading and controlled release, crucial for effective DDS.
  • Chemically-functionalized MOF nanostructures demonstrate significant potential as DDSs for various diseases, particularly cancer.

Conclusions:

  • MOFs represent a highly successful class of nanomaterials for advanced drug delivery systems.
  • Their unique structural and chemical features make them ideal candidates for targeted cancer therapy.
  • Further development of MOF-based DDSs holds significant promise for improving cancer treatment outcomes.